Greenwich Lifesciences Stock Market Value
| GLSI Stock | USD 26.85 1.12 4.35% |
| Symbol | Greenwich |
Is there potential for Biotechnology market expansion? Will Greenwich introduce new products? Factors like these will boost the valuation of Greenwich Lifesciences. Market participants price Greenwich higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Greenwich Lifesciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Greenwich Lifesciences' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Greenwich Lifesciences' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Greenwich Lifesciences' market price signifies the transaction level at which participants voluntarily complete trades.
Greenwich Lifesciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Greenwich Lifesciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Greenwich Lifesciences.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Greenwich Lifesciences on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Greenwich Lifesciences or generate 0.0% return on investment in Greenwich Lifesciences over 90 days. Greenwich Lifesciences is related to or competes with Cognition Therapeutics, Atossa Genetics, Tevogen Bio, Oncolytics Biotech, Surrozen, TuHURA Biosciences, and Seer. Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer imm... More
Greenwich Lifesciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Greenwich Lifesciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Greenwich Lifesciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.87 | |||
| Information Ratio | 0.2288 | |||
| Maximum Drawdown | 36.51 | |||
| Value At Risk | (11.54) | |||
| Potential Upside | 19.77 |
Greenwich Lifesciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Greenwich Lifesciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Greenwich Lifesciences' standard deviation. In reality, there are many statistical measures that can use Greenwich Lifesciences historical prices to predict the future Greenwich Lifesciences' volatility.| Risk Adjusted Performance | 0.2027 | |||
| Jensen Alpha | 1.81 | |||
| Total Risk Alpha | 1.26 | |||
| Sortino Ratio | 0.2791 | |||
| Treynor Ratio | 0.8071 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Greenwich Lifesciences February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2027 | |||
| Market Risk Adjusted Performance | 0.8171 | |||
| Mean Deviation | 6.49 | |||
| Semi Deviation | 5.88 | |||
| Downside Deviation | 6.87 | |||
| Coefficient Of Variation | 419.4 | |||
| Standard Deviation | 8.38 | |||
| Variance | 70.21 | |||
| Information Ratio | 0.2288 | |||
| Jensen Alpha | 1.81 | |||
| Total Risk Alpha | 1.26 | |||
| Sortino Ratio | 0.2791 | |||
| Treynor Ratio | 0.8071 | |||
| Maximum Drawdown | 36.51 | |||
| Value At Risk | (11.54) | |||
| Potential Upside | 19.77 | |||
| Downside Variance | 47.17 | |||
| Semi Variance | 34.52 | |||
| Expected Short fall | (7.55) | |||
| Skewness | 0.4108 | |||
| Kurtosis | 0.0824 |
Greenwich Lifesciences Backtested Returns
Greenwich Lifesciences is somewhat reliable given 3 months investment horizon. Greenwich Lifesciences holds Efficiency (Sharpe) Ratio of 0.27, which attests that the entity had a 0.27 % return per unit of risk over the last 3 months. We are able to interpolate and collect twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.32% are justified by taking the suggested risk. Use Greenwich Lifesciences Downside Deviation of 6.87, risk adjusted performance of 0.2027, and Market Risk Adjusted Performance of 0.8171 to evaluate company specific risk that cannot be diversified away. Greenwich Lifesciences holds a performance score of 21 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 2.46, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Greenwich Lifesciences will likely underperform. Use Greenwich Lifesciences value at risk, and the relationship between the jensen alpha and skewness , to analyze future returns on Greenwich Lifesciences.
Auto-correlation | 0.40 |
Average predictability
Greenwich Lifesciences has average predictability. Overlapping area represents the amount of predictability between Greenwich Lifesciences time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Greenwich Lifesciences price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Greenwich Lifesciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 13.5 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Greenwich Lifesciences Correlation, Greenwich Lifesciences Volatility and Greenwich Lifesciences Performance module to complement your research on Greenwich Lifesciences. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Greenwich Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.